HPV Linked To The Development Of Cervical Cancer
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




HPV Linked To The Development Of Cervical Cancer

BELTSVILLE, MD -- July 6, 1999 -- Results from a six-year prospective clinical study confirmed that persistent infection with high risk human papillomavirus (HPV) is necessary for the development and continuance of CIN (cervical intraepithelial neoplasia) III, the immediate precursor of cervical cancer.

The study was published in the July 3, 1999 issue of The Lancet. In the study, which involved 353 women in The Netherlands who were referred to gynaecologists as a result of mild to moderately abnormal Pap smears, only women with persistent high-risk HPV infection showed clinically progressive disease.

Women without high-risk HPV never developed the critical precursor to cervical cancer. The study concludes that new guidelines for cervical cancer screening can be developed in conjunction with testing for human papillomavirus.

The six-year study was led by professors Chris Meijer and Jan Walboomers, Ph.D., of the department of pathology, The Free University of Amsterdam. The study team concluded that persistent infection with high risk HPV is necessary for development and maintenance of CIN III.

"We clearly showed that a repeated positive HPV test at six months to identify women with CIN III is much better than a repeated Pap smear," the researchers said.

"It appears that the number of false negative cervical smears can be reduced significantly," said professors Meijer and Walboomers.
As a consequence of the study, the researchers advised that women with mild and moderate dysplasia should only be referred for colposcopy and treatment when a second high-risk HPV test is positive.

"This reduces the number of women referred for treatment significantly, without increasing the risk for cervical cancer."

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities